ASX:PBP

Probiotec (PBP) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
26,253 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
2.41%
Price Target
N/A

About Probiotec

Probiotec Limited engages in the development, manufacture, packing, distribution, and sale of prescription and over the counter pharmaceuticals, complementary medicines and consumer health products, and fast-moving consumer products in Australia and internationally. The company provides contract manufacturing services for solid dose tablets, capsules, and caplets; tablets coatings; blister packs, bottles, sachets, tubs, and tubes; liquids, creams, gels, lotions, ointments, and powders and powder blends. It is also involved in analytical and stability testing services; new product formulation and production trials, and ongoing research and development services; and packaging options for human and animal nutrition products, as well as manufactures and exports a range of nutraceuticals and functional ingredient raw materials. The company was incorporated in 1996 and is headquartered in Laverton North, Australia.

PBP Stock News Headlines

Thousands of investors use this no cost solution | Do you?
In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.
Thousands of investors use this no cost solution | Do you?
In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.
PetroVietnam Packaging JSC
Probiotec Limited (PBP.AX)
See More Headlines
Receive PBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Probiotec and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/26/2019
Ex-Dividend for 3/14 Dividend
3/03/2024
Dividend Payable
3/14/2024
Today
4/23/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$8.69 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$221.22 million
Book Value
A$1.09 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.43
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Wesley Stringer B.Comm
    CPA, LLB (Hons), CEO, MD & Executive Director
  • Mr. Jared Stringer B.Comm
    BIT, CPA, CFO, Company Secretary & Financial Controller
  • Ms. Julie McIntosh
    Chief Operating Officer
  • Ms. Annalinde Nickisch
    Chief People Officer
  • Ms. Jessica Walters
    Chief Customer Officer
  • Mr. Alan Hong
    General Manager of Accounting

PBP Stock Analysis - Frequently Asked Questions

How were Probiotec's earnings last quarter?

Probiotec Limited (ASX:PBP) announced its quarterly earnings results on Tuesday, February, 26th. The company reported $0.02 earnings per share for the quarter. Probiotec had a trailing twelve-month return on equity of 10.18% and a net margin of 3.93%.

How often does Probiotec pay dividends? What is the dividend yield for Probiotec?

Probiotec declared a Interim dividend on Friday, March 1st. Investors of record on Thursday, March 14th will be given a dividend of 0.035 per share on Thursday, March 14th. This represents a yield of 1.25%. The ex-dividend date of this dividend is Sunday, March 3rd. This is a boost from the stock's previous Interim dividend of A$0.02.
Read our dividend analysis for PBP
.

Is Probiotec a good dividend stock?

Probiotec (ASX:PBP) pays an annual dividend of A$0.07 per share and currently has a dividend yield of 2.41%. The dividend payout ratio is 70.00%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for PBP.

What other stocks do shareholders of Probiotec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Probiotec investors own include Kalium Lakes (KLL) and 5G Networks (5GN).

This page (ASX:PBP) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners